Cargando…

Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis

Von Hippel-Lindau (VHL) disease is an autosomal dominant condition that predisposes affected individuals to a variety of malignant and benign neoplasms. The pathogenetic turning point of this illness is the accumulation of hypoxia-inducible factor (HIF)-1α, a transcription factor of several genes in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norata, Davide, Peri, Marta, Giammalva, Giuseppe Roberto, Lupica, Antonino, Paolini, Federica, Incorvaia, Lorena, Badalamenti, Giuseppe, Gristina, Valerio, Galvano, Antonio, Russo, Antonio, Iacopino, Domenico Gerardo, Silvestrini, Mauro, Bazan, Viviana, Brighina, Filippo, Di Stefano, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818211/ https://www.ncbi.nlm.nih.gov/pubmed/36611440 http://dx.doi.org/10.3390/diagnostics13010144

Ejemplares similares

Frequency and Correlates of Mild Cognitive Impairment in Myasthenia Gravis
por: Iacono, Salvatore, et al.
Publicado: (2023)

Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows
por: Vinciguerra, Claudia, et al.
Publicado: (2023)

Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study
por: Di Stefano, Vincenzo, et al.
Publicado: (2022)

Von Hippel-Lindau Disease
por: Hes, Frederik J, et al.
Publicado: (2005)

Von Hippel-Lindau Disease and the Eye
por: Karimi, Saeed, et al.
Publicado: (2020)

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
por: Lupica, Antonino, et al.
Publicado: (2022)

Invasive management of renal cell carcinoma in von Hippel-Lindau disease
por: Carrion, Diego M., et al.
Publicado: (2020)

Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
por: Incorvaia, Lorena, et al.
Publicado: (2019)

A Review of Von Hippel-Lindau Syndrome
por: Varshney, Neha, et al.
Publicado: (2017)

Cardiac Involvement in Von Hippel-Lindau Disease
por: Valero, Ernesto, et al.
Publicado: (2016)

Ocular Manifestations of von Hippel-Lindau Disease
por: Ruppert, Misty D, et al.
Publicado: (2019)

Clinical Signs in Neuro-Ophthalmology: Eye Signs in Myasthenia Gravis
por: Wong, Sui Hsien
Publicado: (2022)

Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1
por: Badalamenti, Giuseppe, et al.
Publicado: (2019)

Hemangioblastomatosis in a patient with von Hippel-Lindau disease
por: Hanse, M. C. J., et al.
Publicado: (2007)

The incidence of consecutive manifestations in Von Hippel-Lindau disease
por: van der Horst-Schrivers, Anouk N. A., et al.
Publicado: (2019)

Pathology of the Nervous System in Von Hippel-Lindau Disease
por: Vortmeyer, Alexander O., et al.
Publicado: (2015)

Resection of von Hippel Lindau Related Brainstem Hemangioblastoma
por: Maggio, Dominic, et al.
Publicado: (2019)

Clear cell chondrosarcoma in Von Hippel-Lindau disease
por: Dreijerink, Koen M. A., et al.
Publicado: (2019)

Von Hippel-Lindau Disease Presenting as Obstructive Jaundice
por: Giri, Suprabhat, et al.
Publicado: (2020)

Von Hippel-Lindau syndrome with pancreatic adenocarcinoma (with videos)
por: Zhang, Chenchen, et al.
Publicado: (2021)

Von Hippel-Lindau disease: A case report
por: Neupane, Durga, et al.
Publicado: (2022)

Vestibular Function in Children With Von Hippel–Lindau Disease
por: Fatih Turgut, Nesrettin, et al.
Publicado: (2021)

PANCREATODUODENECTOMY IN PATIENT WITH VON HIPPEL-LINDAU DISEASE: A LITERATURE REVIEW
por: Eulálio, José Marcus Raso, et al.
Publicado: (2022)

Synchronous Presentation of Rare Brain Tumors in Von Hippel–Lindau Syndrome
por: Lodi, Mariachiara, et al.
Publicado: (2021)

Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement
por: Badalamenti, Giuseppe, et al.
Publicado: (2022)

MuSK-Associated Myasthenia Gravis: Clinical Features and Management
por: Rodolico, Carmelo, et al.
Publicado: (2020)

A case of von Hippel-Lindau disease with exudative maculopathy
por: Ba′arah, Basel T.
Publicado: (2009)

Von Hippel-Lindau Syndrome: Diagnosis and Management of Hemangioblastoma and Pheochromocytoma
por: Vaganovs, P., et al.
Publicado: (2013)

Mosaicism in von Hippel-Lindau disease: an event important to recognize
por: Santarpia, Libero, et al.
Publicado: (2007)

Falcine meningioma in Von Hippel–Lindau disease: An unusual association
por: Murrone, Domenico, et al.
Publicado: (2018)

Pilot study of dovitinib in patients with von Hippel-Lindau disease
por: Pilié, Patrick, et al.
Publicado: (2018)

Hemangioblast: origin of hemangioblastoma in von Hippel-Lindau (VHL) syndrome
por: Wang, Herui, et al.
Publicado: (2018)

Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma
por: Ashouri, Kenan, et al.
Publicado: (2015)

Von Hippel-Lindau Disease: The Importance of Retinal Hemangioblastomas in Diagnosis
por: Şahin Atik, Sevinç, et al.
Publicado: (2017)

Von Hippel-Lindau Disease: Current Challenges and Future Prospects
por: Gläsker, Sven, et al.
Publicado: (2020)

The Endothelial Landscape and Its Role in Von Hippel–Lindau Disease
por: de Rojas-P, Isabel, et al.
Publicado: (2021)

Familial multiple sclerosis in patients with Von Hippel-Lindau disease
por: Nath, Samir R., et al.
Publicado: (2022)

The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis
por: Hudler, Petra, et al.
Publicado: (2022)

Challenges in Von Hippel–Lindau’s disease: PRRT in patients on hemodialysis
por: Ayub, N, et al.
Publicado: (2022)

Von Hippel Lindau Disease Presenting as Cervical Compressive Myelopathy
por: Aliyar, Aminu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_klad04us4grpj9am9m3rui3arn